XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   26,335,418      
Beginning balance at Dec. 31, 2021 $ 127,115 $ 3 $ 324,237 $ (252) $ (196,873)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (20,808)       (20,808)
Stock-based compensation 2,069   2,069    
Foreign exchange translation adjustment (58)     (58)  
Shares issued from exercise of pre-funded warrants (in shares)   2,904,113      
Shares issued from exercise of pre-funded warrants 29,638   29,638    
Issuance of common stock (in shares)   852      
Issuance of common stock 5   5    
Ending balance (in shares) at Mar. 31, 2022   29,240,383      
Ending balance at Mar. 31, 2022 $ 137,961 $ 3 355,949 (310) (217,681)
Beginning balance (in shares) at Dec. 31, 2022 39,307,286 39,307,286      
Beginning balance at Dec. 31, 2022 $ 113,684 $ 4 427,925 3,035 (317,280)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (25,272)       (25,272)
Stock-based compensation 1,979   1,979    
Foreign exchange translation adjustment 776     776  
Shares issued from exercise of pre-funded warrants (in shares)   5,096,552      
Shares issued from exercise of pre-funded warrants $ 51   51    
Ending balance (in shares) at Mar. 31, 2023 44,403,838 44,403,838      
Ending balance at Mar. 31, 2023 $ 91,218 $ 4 $ 429,955 $ 3,811 $ (342,552)